A. Corregidor

发表

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Brian L. Pearlman, Z. Younossi, S. Ouwerkerk-Mahadevan, 2014, The Lancet.

svr results of a once-daily regimen of simeprevir (tmc435) plus sofosbuvir (gs-7977) with or without ribavirin in cirrhotic and non-cirrhotic Hcv genotype 1 treatment-naïve and prior null responder patients: The Cosmos study : lb-3

Brian L. Pearlman, Z. Younossi, S. Ouwerkerk-Mahadevan, 2013 .

O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)

Brian L. Pearlman, Z. Younossi, S. Ouwerkerk-Mahadevan, 2014 .

O7 ONCE-DAILY SIMEPREVIR (TMC435) PLUS SOFOSBUVIR (GS-7977) WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL RESPONDERS WITH METAVIR F0–2: COSMOS STUDY SUBGROUP ANALYSIS

Z. Younossi, S. Ouwerkerk-Mahadevan, M. Sulkowski, 2014 .

Extraction of hollow gastric foreign bodies by flexible upper endoscopy assisted by a through-the-scope balloon catheter for anchoring.

K. Vega, J. Munoz, Ruchi Gupta, 2008, Gastrointestinal endoscopy.

Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection

M. Gamil, S. Ouwerkerk-Mahadevan, W. Smith, 2018, Journal of viral hepatitis.

Modified technique to extract malpositioned or migrated self‐expanding stents from the esophagus and stomach

K. Vega, J. Munoz, J. Khoury, 2009, Journal of gastroenterology and hepatology.

Sa2073 SVR4 Results of a Once Daily Regimen of Simeprevir (TMC435) Plus Sofosbuvir (GS-7977) With or Without Ribavirin (RBV) in HCV GT 1 Null Responders

Z. Younossi, I. Jacobson, E. Lawitz, 2013 .

LB-1 Phase 2b study of the interferon-free and ribavirin-free combination of daclatasvir, asunaprevir, and BMS-791325 for 12 weeks in treatment-naïve patients with chronic HCV genotype 1 infection

Z. Younossi, S. Ouwerkerk-Mahadevan, M. Sulkowski, 2013 .